Summary & Overview
HCPCS Q4396: Natalin, Per Square Centimeter (Add-On)
HCPCS Level II code Q4396 denotes Natalin billed per square centimeter as an add-on code to be reported in addition to a primary procedure. The code captures use of a topical or localized biologic/dermatologic product applied over a measured treatment area. Nationally, clear reporting of add-on topical product codes affects claim adjudication, reimbursement accuracy, and clinical documentation related to procedure-level resource use.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code's clinical context, standard sites of service, and typical billing practice for an add-on topical product. The publication summarizes common modifiers submitted with this code and notes where input data is unavailable.
The piece provides benchmarks and policy-relevant items: how add-on HCPCS codes like Q4396 are typically processed by major payers, documentation elements that support medical necessity for an add-on topical application, and practical billing considerations for outpatient procedural settings. Where specific payer coverage details or pricing benchmarks are not provided, the text notes that the data was not available in the input. This national-level summary is intended to clarify the code's purpose and the payer landscape for clinicians, coders, and revenue professionals handling Natalin as a per-square-centimeter add-on.
Billing Code Overview
HCPCS Level II code Q4396 represents Natalin, billed per square centimeter as an add-on service that must be listed separately in addition to a primary procedure. This code is used for billing a topical or local product applied to a treatment area and is typically associated with procedures that require a measured application area.
Service Type: Topical/local biologic or dermatologic product application (add-on)
Typical Site of Service: Outpatient procedural settings, including ambulatory surgery centers, hospital outpatient departments, and clinic procedure rooms where topical or localized biologic agents are applied during a primary procedure.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A patient presents to a dermatology or wound-care clinic with a superficial to partial-thickness skin defect requiring biologic dressing or topical skin substitute application. The clinician determines that a per-square-centimeter application of a topical skin substitute product (Natalin) is appropriate as an add-on to the primary debridement, excision, grafting, or topical wound care procedure. Typical workflow: initial evaluation and wound assessment, cleansing/debridement of the wound bed, measurement of the treated surface area in square centimeters, preparation of the Natalin material, application of Natalin to the prepared wound surface, and documentation of square centimeters applied and linkage to the primary procedure. Typical site of service is an outpatient dermatology clinic, ambulatory surgery center, or hospital outpatient department where minor procedures and biologic dressing applications are performed. A realistic patient scenario: a 62-year-old patient with a chronic venous leg ulcer following debridement in clinic receives Natalin applied to a 15 cm2 area as an adjunct to the primary wound debridement procedure; documentation includes wound measurements, product lot number, and the primary procedure code to which Q4396 is appended as an add-on.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When work or complexity substantially exceeds usual for the primary procedure and additional documentation supports increased resources in applying the topical skin substitute |